2023 will see continued packaging consolidation, increased device viscosity capabilities and a more forgiving MDR runway Paris – Ahead of next week’s returning Pharmapack Europe 2023 (February 1-2) the event’s panel of experts predict increased consolidations in 2023 – driven by supply chain concerns and big pharma preferences – a relaxation of MDR deadlines and high viscosity delivery as the biggest area of device innovation. The event – which is at the heart of pharma’s packaging and drug delivery devices industry – returns to the Paris Expo, Porte de Versailles (Hall 7.2) and will see 5500 attendees and over 300 companies exploring next
The post Experts advise European SME packaging firms to expand or seek acquisition prior to Pharmapack Europe appeared first on Pharma Mirror Magazine.
